{
  "context": {
    "rules": [
      "Rule1: If John Doe is an authorized researcher for Study Alpha, then he is also an authorized researcher for Study Beta.",
      "Rule2: Whenever a regulatory hearing has been scheduled for Medixol, a committee review has been completed for Medixol.",
      "Rule3: Given that a committee review has been completed for Medixol, Medixol is approved in the Northwest Region.",
      "Rule4: If the Medixol Study has passed a compliance audit, then it follows that if it is not the case that it is not the case that it is not the case that if a research job has been assigned to John Doe for the Medixol Study, then if Medixol does not adhere to good manufacturing practices, the clinical trial for Medixol has been completed, then it is not the case that a protocol deviation has been detected in the Medixol Study, then an investigation has been launched into the Medixol Study, then regulatory approval is granted for Medixol.",
      "Rule5: Provided that manufacturing standards have been met for Medixol, it is not the case that regulatory sanctions have been imposed on the Medixol Study.",
      "Rule6: If an alternative approval route has been used for Medixol, then regulatory sanctions have not been imposed on the Medixol Study.",
      "Rule7: If peer review is positive for the Medixol Study, then if the research phase has been completed for the Medixol Study, should Medixol not adhere to good manufacturing practices, the clinical trial for Medixol has been completed.",
      "Rule8: Provided that an expedited review has been requested for the Medixol Study, then if the research phase has been completed for the Medixol Study, whenever Medixol does not adhere to good manufacturing practices, the clinical trial for Medixol has been completed.",
      "Rule9: Given that data integrity has been verified for the Medixol Study, the methodology is robust for the Medixol Study.",
      "Rule10: Either data integrity has been verified for the Medixol Study or preliminary results are promising for the Medixol Study.",
      "Rule11: Whenever preliminary results are promising for the Medixol Study, an expedited review has been requested for the Medixol Study.",
      "Rule12: Under the condition that statistical analysis is sound for the Medixol Study, peer review is positive for the Medixol Study.",
      "Rule13: Provided that the methodology is robust for the Medixol Study, statistical analysis is sound for the Medixol Study.",
      "Rule14: Adverse events have been reported for the Medixol Study or it is not the case that the trial has been suspended for the Medixol Study.",
      "Rule15: If safety monitoring is ongoing for the Medixol Study, then adverse events have not been reported for the Medixol Study.",
      "Rule16: Given that an interim analysis has been conducted for the Medixol Study, the clinical trial for Medixol has been completed.",
      "Rule17: Patient recruitment is complete for the Medixol Study or if Medixol does not adhere to good manufacturing practices, then an interim analysis has been conducted for the Medixol Study.",
      "Rule18: Under the condition that Medixol is approved in the Southeast Region, Medixol is approved in the Northwest Region.",
      "Rule19: Provided that a research job has been assigned to John Doe for the Medixol Study, the research phase has been completed for the Medixol Study.",
      "Rule20: If it is not the case that if efficacy data has been submitted for Medixol, then regulatory approval is granted for Medixol, then safety concerns have been identified for Medixol.",
      "Rule21: Under the condition that it is not the case that if efficacy data has been submitted for Medixol, then regulatory approval is granted for Medixol, it is not the case that safety concerns have been identified for Medixol.",
      "Rule22: If it is not the case that manufacturing standards have been met for Medixol or an alternative approval route has been used for Medixol, then emergency use authorization has been granted for Medixol.",
      "Rule23: Provided that it is not the case that if John Doe is an authorized researcher for Study Beta, then Medixol adheres to good manufacturing practices, a regulatory hearing has been scheduled for Medixol.",
      "Rule24: If it is not the case that if a research job has been assigned to John Doe for the Medixol Study, then if Medixol does not adhere to good manufacturing practices, the clinical trial for Medixol has been completed, then a protocol deviation has been detected in the Medixol Study.",
      "Rule25: If it is not the case that if it is not the case that if John Doe is an authorized researcher for Study Beta, then Medixol adheres to good manufacturing practices, then Medixol is approved in the Southeast Region, then Medixol is approved in the Central Region.",
      "Rule26: Under the condition that it is not the case that if it is not the case that it is not the case that if a research job has been assigned to John Doe for the Medixol Study, then if Medixol does not adhere to good manufacturing practices, the clinical trial for Medixol has been completed, then it is not the case that a protocol deviation has been detected in the Medixol Study, then an investigation has been launched into the Medixol Study, then efficacy data has been submitted for Medixol.",
      "Rule27: If it is not the case that if Medixol does not adhere to good manufacturing practices, then the clinical trial for Medixol has been completed, then the trial has been suspended for the Medixol Study.",
      "Rule28: Provided that the Medixol Study has not passed a compliance audit, regulatory sanctions have been imposed on the Medixol Study."
    ],
    "facts": [
      "Fact1: John Doe is an authorized researcher for Study Alpha.",
      "Fact2: Safety monitoring is ongoing for the Medixol Study.",
      "Fact3: A research job has been assigned to John Doe for the Medixol Study.",
      "Fact4: It is not the case that regulatory approval has been granted for Medixol.",
      "Fact5: It is not the case that emergency use authorization has been granted for Medixol.",
      "Fact6: It is not the case that Medixol is approved in the Northwest Region.",
      "Fact7: It is not the case that patient recruitment is complete for the Medixol Study.",
      "Fact8: It is not the case that Medixol is approved in the Central Region.",
      "Fact9: It is not the case that the clinical trial for Medixol has been completed.",
      "Fact10: It is not the case that an investigation has been launched into the Medixol Study."
    ]
  },
  "question": "Medixol adheres to good manufacturing practices."
}